Research in community-acquired pneumonia: the next steps

Intensive Care Medicine

Volumn 43, Issue 9, 2017, Pages 1395-1397

  Torres, Antoni ^a   Martín Loeches, Igancio ^b   Menéndez, Rosario ^c  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b ST JAMES S HOSPITAL   (Ireland)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; MACROLIDE;

ADJUVANT THERAPY; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL RESEARCH; COMMUNITY ACQUIRED PNEUMONIA; HUMAN; INFLUENZA; MORTALITY; PANDEMIC; PROGNOSIS; STEROID THERAPY; COMMUNITY ACQUIRED INFECTION; COMPLICATION; GLOBAL HEALTH; INTENSIVE CARE; INTENSIVE CARE UNIT; METHODOLOGY; MIXED INFECTION; PNEUMONIA; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STANDARDS; STATISTICS AND NUMERICAL DATA;

COINFECTION; COMMUNITY-ACQUIRED INFECTIONS; CRITICAL CARE; GLOBAL HEALTH; HUMANS; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; PANDEMICS; PNEUMONIA; RESEARCH DESIGN; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 85017644464     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-017-4774-4     Document Type: Article

References (17)

1. Mongardon N, Max A, Bouglé A et al (2012) Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study. Crit Care 16(4):R155
2. Meerhoff TJ, Simaku A, Ulqinaku D et al (2015) Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region-an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases. BMC Infect Dis 15:1–12
3. Sakr Y, Ferrer R, Reinhart K et al (2016) The intensive care global study on severe acute respiratory infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study. Intensive Care Med 42(5):817–828
4. Martin-Loeches I, van Someren Gréve F, Schultz MJ (2017) Bacterial pneumonia as an influenza complication. Curr Opin Infect Dis. 30(2):201–207
5. Martin-Loeches I, Soares M, Torres A (2016) Neces-SARI-ly? Intensive Care Med 42(5):928–930
6. Martin-Loeches I, Schultz MJ, Vincent J-L et al (2017) Increased incidence of co-infection in critically ill patients with influenza. Intensive Care Med 43(1):48–58
7. Rodríguez AH, Avilés-Jurado FX, Díaz E et al (2016) Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: a CHAID decision-tree analysis. J Infect 72(2):143–151
8. Torres A, Sibila O, Ferrer M et al (2015) Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 313(7):677–686
9. Bi J, Yang J, Wang Y et al (2016) Efficacy and safety of adjunctive corticosteroids therapy for severe community-acquired pneumonia in adults: an updated systematic review and meta-analysis. PLoS One 11(11):e0165942
10. Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS (2016) Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev 3:CD010406
11. Sligl WI, Asadi L, Eurich DT, Tjosvold L, Marrie TJ, Majumdar SR (2014) Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis. Crit Care Med 42(2):420–432
12. Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. doi:10.1007/s00134-017-4683-6
13. Welte T, Dellinger RP, Ebelt H et al (2015) Concept for a study design in patients with severe community-acquired pneumonia: a randomised controlled trial with a novel IGM-enriched immunoglobulin preparation—the CIGMA study. Respir Med 109(6):758–767
14. Mortensen EM, Metersky ML (2012) Long-term mortality after pneumonia. Semin Respir Crit Care Med. 33(3):319–324
15. Eurich DT, Marrie TJ, Minhas-Sandhu JK, Majumdar SR (2015) Ten-year mortality after community-acquired pneumonia. A prospective cohort. Am J Respir Crit Care Med 192(5):597–604
16. Menéndez R, Montull B, Reyes S et al (2016) Pneumonia presenting with organ dysfunctions: causative microorganisms, host factors and outcome. J Infect 73(5):419–426
17. Benz F, Roy S, Trautwein C, Roderburg C, Luedde T (2016) Circulating microRNAs as biomarkers for sepsis. Int J Mol Sci 17(1):78